August 24, 2011
The objective of this session is to understand how regulatory, reimbursement, and commercialization activities were developed for a new therapy and a companion diagnostic. Specific milestones and timelines will be discussed so that the audience can benchmark their own experiences and future plans. Next Generation Dx Summit, Washington D.C. August 25, 2011
Subscribe